ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer
ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer have?
ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer has 88 citations in the OpenAlex counts PICO Portal stores.
When was ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer published?
ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer has 2016 year in the PICO Portal index.
What is the open-access status of ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer?
ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer has bronze oa status in the PICO Portal index.
What is the DOI of ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer?
The DOI for ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer is on the source record.
What is the PMID of ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer?
The PMID for ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer is on the source record.
What is the OpenAlex record for ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer?
The OpenAlex for ProCare Trial: a phase <scp>II</scp> randomized controlled trial of shared care for follow‐up of men with prostate cancer is on the source record.